an extract from the DNDN website about the Medicare situation with Provenge. You will see that:
"Medicare beneficiaries are still able to access PROVENGE and private payers can also still cover PROVENGE.
cheers
Birdseye
here is the extract:
Dendreon Statement on Centers for Medicare and Medicaid Services- CMS
SEATTLE, June 30, 2010
In the announcement, ---CMS is requesting public comments on the effects of PROVENGE on health outcomes in patients with prostate cancer.
It is NOT a change in Medicare coverage policy.
---not impact existing coverage decisions, nor do they restrict local Medicare contractors from covering PROVENGE.
Therefore, Medicare beneficiaries are still able to access PROVENGE and private payers can also still cover PROVENGE.
Dendreon welcomes the opportunity to continue our discussions with CMS about how PROVENGE will be provided to Medicare beneficiaries, particularly given the survival benefit and safety profile of PROVENGE. 'We plan on continuing to work closely with CMS during this process to ensure patients with advanced prostate cancer have broad access to PROVENGE.'
Source:http://investor.dendreon.com/phoenix.zhtml?c=120739&p=irol-newsArticle&ID=1443313&highlight=
an extract from the DNDN website about the Medicare situation...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |